SCHEMBL7330964

SCHEMBL7330964

Cc1ccc(-c2ccc(C)c(CN3CCN(C(c4ccccc4)c4ccccc4)CC3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.58
▸ CYP2C19 P33261 2/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ USP2 O75604 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ HPN P05981 1/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ CHRM1 P11229 1/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ ADRA2C P18825 1/20 0.50
▸ CNR1 P21554 1/20 0.50
▸ DRD1 P21728 1/20 0.50
▸ DRD4 P21917 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ HRH2 P25021 1/20 0.50
▸ HTR2A P28223 1/20 0.50
▸ SLC6A4 P31645 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27463912 0.95 OPRD1 (0.53) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL7336021 0.90 ACHE (0.60) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL8989126 0.88 LMNA (0.48) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL8989095 0.87 CYP2D6 (0.48) CYP3A4CYP2C19CYP2C9USP2CYP1A2
Hydrochloric Acid SCHEMBL7326590 0.86 CYP2D6 (0.47) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL7335540 0.84 LMNA (0.48) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL7328864 0.82 CYP3A4 (0.65) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL16227069 0.81 KMT2A (0.61) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL8271488 0.80 CYP3A4 (0.55) CYP3A4CYP2C19CYP2C9USP2CYP1A2
SCHEMBL16226272 0.78 LMNA (0.70) CYP3A4CYP2C19CYP2C9USP2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 — — US claimed
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 — — US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 — — EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 — — US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 — — WO disclosed
Send feedback